Email updates

Keep up to date with the latest news and content from Lipids in Health and Disease and BioMed Central.

Open Access Short report

Dihydrotestosterone induces SREBP-1 expression and lipogenesis through the phosphoinositide 3-kinase/Akt pathway in HaCaT cells

Bing-rong Zhou, Qiu-hong Huang, Yang Xu, Di Wu, Zhi-qiang Yin and Dan Luo*

Author affiliations

Department of Dermatology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

For all author emails, please log on.

Citation and License

Lipids in Health and Disease 2012, 11:156  doi:10.1186/1476-511X-11-156

Published: 15 November 2012

Abstract

Background

The purpose of this study was to investigate the effects and mechanisms of dihydrotestosterone (DHT)-induced expression of sterol regulatory element binding protein-1 (SREBP-1), and the synthesis and secretion of lipids, in HaCaT cells. HaCaT cells were treated with DHT and either the phosphoinositide 3-kinase inhibitor LY294002 or the extracellular-signal-regulated kinase (ERK) inhibitor PD98059. Real time-PCR, Western blot, Oil Red staining and flow cytometry were employed to examine the mRNA and protein expressions of SREBP-1, the gene transcription of lipid synthesis, and lipid secretion in HaCaT cells.

Findings

We found that DHT upregulated mRNA and protein expressions of SREBP-1. DHT also significantly upregulated the transcription of lipid synthesis-related genes and increased lipid secretion, which can be inhibited by the addition of LY294002.

Conclusions

Collectively, these results indicate that DHT induces SREBP-1 expression and lipogenesis in HaCaT cells via activation of the phosphoinositide 3-kinase/Akt Pathway.

Keywords:
Dihydrotestosterone; SREBP-1; Phosphoinositide 3-kinase/Akt; HaCaT cells